The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Recce Pharmaceuticals (ASX:RCE) winds up the September quarter with $8 million in cash
  • The company has registered a new trademark in Vietnam
  • Recce’s R327 trials continue to support the company’s thesis its flagship anti-infective is superior to mainstream competitor treatments
  • Shares last traded at 43.5 cents

Recce Pharmaceutical (ASX:RCE), an ASX-listed company developing a class of anti-infective drugs for the treatment of multiple conditions, has revealed it closed September with $8 million in cash.

Across the quarter, the company wasted no time or energy in progressing itself to becoming a high-impact medical heavyweight.

The company had to shake the tin for $10.7 million, but with the company’s phase one clinical trial data published, the capital wasn’t hard to find.

The company’s flagship Recce 327 drug appears to be a superior drug for the treatment of UTIs, as well as boasting piecemeal evidence the topical gel version can successfully mitigate diabetes-related infections from surgical wounds.

The company also made its first move into Vietnam.

Recce filed four patents with the Australian regulator across the quarter, too. It won back $0.8 million from research and development tax schemes and also won sponsorship from Australia’s trade body Austrade.

That sponsorship saw Recce attend a medical conference in Japan, letting the world know this little Aussie battler was here to shake things up.

RCE shares last traded at 43.5 cents.

rce by the numbers
More From The Market Online

KPMG Australia cuts 387 roles as scandal, weak consulting demand hit outlook

KPMG Australia is cutting 27 partners and about 360 staff as revenue slips and the firm…
The Market Online Video

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Askari Metals Executive Director Gino D’Anna discusses the company’s Ethiopia strategy, permitting progress, and broader portfolio…
The ASX Today feature image with a green bull silhouette (RISE) beside The Market Link column branding.

ASX Today: Miners lift market as gold hits three month high

The ASX is pushing higher at lunchtime, with miners leading the charge as gold climbs to…
HotCopper Daily Market Trends Graphic

Monday’s HotCopper trends: DXN, Right Resources, North Stawell Minerals and other daily topics

With more than 600k average monthly users on the HotCopper forums, each and every discussion can…